Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Brough

Showing results (41-50 of 140) with videos related to

Pageof 14
Sort By:
The Journal of Biological Chemistry|September 12, 2013
Acidosis drives damage-associated molecular pattern (DAMP)-induced interleukin-1 secretion via a caspase-1-independent pathwayMichelle E Edye, Gloria Lopez-Castejon, Stuart M Allan, et al.
The FEBS Journal|November 4, 2020
Bafilomycin A1 enhances NLRP3 inflammasome activation in human monocytes independent of lysosomal acidificationShi Yu, Jack Green, Rose Wellens, et al.
Immunology|February 9, 2022
Itaconate and fumarate derivatives inhibit priming and activation of the canonical NLRP3 inflammasome in macrophagesChristopher Hoyle, Jack P Green, Stuart M Allan, et al.
Plos One|May 8, 2012
Inhibition of calpain blocks the phagosomal escape of Listeria monocytogenesGloria Lopez-Castejon, David Corbett, Marie Goldrick, et al.
Neuropharmacology|September 12, 2007
A selective, non-peptide caspase-1 inhibitor, VRT-018858, markedly reduces brain damage induced by transient ischemia in the ratJerard Ross, David Brough, Rosemary M Gibson, et al.
Journal of Neuroinflammation|December 31, 2011
Interleukin-1α expression precedes IL-1β after ischemic brain injury and is localised to areas of focal neuronal loss and penumbral tissuesNadia M Luheshi, Krisztina J Kovács, Gloria Lopez-Castejon, et al.
The Journal of Biological Chemistry|May 3, 2014
Release of interleukin-1α or interleukin-1β depends on mechanism of cell deathHazel England, Holly R Summersgill, Michelle E Edye, et al.
Brain Communications|November 2, 2020
Anti-inflammatories in Alzheimer's disease-potential therapy or spurious correlate?Jack Rivers-Auty, Alison E Mather, Ruth Peters, et al.
The Journal of Biological Chemistry|November 14, 2001
Priming of macrophages with lipopolysaccharide potentiates P2X7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine productionRosalind A Le Feuvre, David Brough, Yoichiro Iwakura, et al.
Clinical Immunology (Orlando, Fla.)|March 12, 2023
The NLRP3 inflammasome as a target for sensorineural hearing lossGrace E Gregory, Kevin J Munro, Kevin N Couper, et al.
Pageof 14

Showing results (41-50 of 140) with videos related to

Sort By:
Pageof 14
The Journal of Biological Chemistry|September 12, 2013
Acidosis drives damage-associated molecular pattern (DAMP)-induced interleukin-1 secretion via a caspase-1-independent pathwayMichelle E Edye, Gloria Lopez-Castejon, Stuart M Allan, et al.
The FEBS Journal|November 4, 2020
Bafilomycin A1 enhances NLRP3 inflammasome activation in human monocytes independent of lysosomal acidificationShi Yu, Jack Green, Rose Wellens, et al.
Immunology|February 9, 2022
Itaconate and fumarate derivatives inhibit priming and activation of the canonical NLRP3 inflammasome in macrophagesChristopher Hoyle, Jack P Green, Stuart M Allan, et al.
Plos One|May 8, 2012
Inhibition of calpain blocks the phagosomal escape of Listeria monocytogenesGloria Lopez-Castejon, David Corbett, Marie Goldrick, et al.
Neuropharmacology|September 12, 2007
A selective, non-peptide caspase-1 inhibitor, VRT-018858, markedly reduces brain damage induced by transient ischemia in the ratJerard Ross, David Brough, Rosemary M Gibson, et al.
Journal of Neuroinflammation|December 31, 2011
Interleukin-1α expression precedes IL-1β after ischemic brain injury and is localised to areas of focal neuronal loss and penumbral tissuesNadia M Luheshi, Krisztina J Kovács, Gloria Lopez-Castejon, et al.
The Journal of Biological Chemistry|May 3, 2014
Release of interleukin-1α or interleukin-1β depends on mechanism of cell deathHazel England, Holly R Summersgill, Michelle E Edye, et al.
Brain Communications|November 2, 2020
Anti-inflammatories in Alzheimer's disease-potential therapy or spurious correlate?Jack Rivers-Auty, Alison E Mather, Ruth Peters, et al.
The Journal of Biological Chemistry|November 14, 2001
Priming of macrophages with lipopolysaccharide potentiates P2X7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine productionRosalind A Le Feuvre, David Brough, Yoichiro Iwakura, et al.
Clinical Immunology (Orlando, Fla.)|March 12, 2023
The NLRP3 inflammasome as a target for sensorineural hearing lossGrace E Gregory, Kevin J Munro, Kevin N Couper, et al.
Pageof 14